Urinary monocyte chemotactic protein-1 and transforming growth factor-β in systemic lupus erythematosus

Indian Journal of Nephrology

Volumn 22, Issue 1, 2012, Pages 5-12

  Torabinejad, S ^a,b   Mardani, R ^b   Habibagahi, Z ^c   Roozbeh, J ^a,c   Khajedehi, P ^a,c   Pakfetrat, M ^a,c   Banihashemi, M A ^a,c   Banihashemi, S J ^a,c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Department of Pathology ^*  (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Lupus nephritis; monocyte chemotactic protein 1; systemic lupus erythematosus; transforming growth factor beta

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA2;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PROTEIN URINE LEVEL; RECEIVER OPERATING CHARACTERISTIC; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84861083088     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.91179     Document Type: Article

References (38)

1. Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: Estimates obtained using hospitalization data. Arthritis Rheum 2007; 56: 2092-4.
2. Pons-Estel GJ, Alarcón GS, Scofield L, Reinlib L, Cooper GS. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 2010; 39: 257-68.
3. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41: 778-99. (Pubitemid 28225778)
4. Firestein GS. Kelley's Textbook of Rheumatology. Philadelphia: Elsevier WB Saunders; 2008. p. 1270.
5. Zabaleta-Lanz ME, Muñoz LE, Tapanes FJ, Vargas-Arenas RE, Daboin I, Barrios Y, et al. Further description of early clinically silent lupus nephritis. Lupus 2006; 15: 845-51. (Pubitemid 46049690)
6. Leehey DJ, Katz AI, Azaran AH, Aronson AJ, Spargo BH. Silent diffuse lupus nephritis: Long-term follow-up. Am J Kidney Dis 1982; 2: 188-96. (Pubitemid 13230792)
7. Wada Y, Ito S, Ueno M, Nakano M, Arakawa M, Gejyo F. Renal outcome and predictors of clinical renal involvement in patients with silent lupus nephritis. Nephron Clin Pract 2004; 98: c105-11. (Pubitemid 40069641)
8. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Systemic lupus erythematosus: Clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1993; 72: 113-24. (Pubitemid 23097765)
9. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003; 82: 299-308. (Pubitemid 37229465)
10. Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore) 2006; 85: 147-56. (Pubitemid 43833013)
11. Alarcón GS, McGwin G Jr, Petri M, Reveille JD, Ramsey- Goldman R, Kimberly RP, et al. Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 2002; 11: 95-101. (Pubitemid 34259439)
12. To CH, Petri M. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis Rheum 2005; 52: 4003-10. (Pubitemid 41798240)
13. Ward MM. Changes in the incidence of endstage renal disease due to lupus nephritis in the United States, 1996-2004. J Rheumatol 2009; 36: 63-7.
14. Li Y, Tucci M, Narain S, Barnes EV, Sobel ES, Segal MS, et al. Urinary biomarkers in lupus nephritis. Autoimmun Rev 2006; 5: 383-8. (Pubitemid 44143030)
15. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients: The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-40.
16. Segerer S, Nelson PJ, Schlöndorff D. Chemokines, chemokine receptors, and renal disease: From basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000; 11: 152-76. (Pubitemid 30020438)
17. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65: 521-30. (Pubitemid 38130646)
18. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al., The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15: 241-50. (Pubitemid 38140764)
19. Furness PN, Taub N. Interobserver reproducibility and application of the ISN/RPS classification of lupus nephritis-a UK-wide study. Am J Surg Pathol 2006; 30: 1030-5. (Pubitemid 44264954)
20. Chan RW, Lai FM, Li EK, Tam LS, Chow KM, Lai KB, et al. Intrarenal cytokine gene expression in lupus nephritis. Ann Rheum Dis 2007; 66: 886-92. (Pubitemid 46999788)
21. Hammad AM, Youssef HM, El-Arman MM. Transforming growth factor beta 1 in children with systemic lupus erythematosus: A possible relation with clinical presentation of lupus nephritis. Lupus 2006; 15: 608-12. (Pubitemid 44661750)
22. Rovin BH, Birmingham DJ, Nagaraja HN, Yu CY, Hebert LA. Biomarker discovery in human SLE nephritis. Bull NYU Hosp Jt Dis 2007; 65: 187-93. (Pubitemid 351412131)
23. Chan RW, Lai FM, Li EK, Tam LS, Wong TY, Szeto CY, et al., Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis. Arthritis Rheum 2004; 50: 2882-90. (Pubitemid 39209526)
24. Chan RW, Lai FM, Li EK, Tam LS, Chow KM, Li PK, et al. The effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis. Nephrol Dial Transplant 2006; 21: 1534-40. (Pubitemid 43834636)
25. Wada T, Yokoyama H, Su SB, Mukaida N, Iwano M, Dohi K, et al. Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int 1996; 49: 761-7. (Pubitemid 26093085)
26. Noris M, Bernasconi S, Casiraghi F, Sozzani S, Gotti E, Remuzzi G, et al. Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Lab Invest 1995; 73: 804-9. (Pubitemid 26002339)
27. Illei GG, Takada K, Parkin D, Austin HA, Crane M, Yarboro CH, et al. Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: Long-term followup of a cohort of 145 patients participating in randomized controlled studies. Arthritis Rheum 2002; 46: 995-1002. (Pubitemid 34303812)
28. Moroni G, Quaglini S, Maccario M, Banfi G, Ponticelli C. "Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int 1996; 50: 2047-53. (Pubitemid 26417549)
29. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7. (Pubitemid 13221242)
30. Grande JP, Balow JE, Renal biopsy in lupus nephritis. Lupus. 1998; 7: 611-7. (Pubitemid 29008227)
31. Tucci M, Calvani N, Richards HB, Quatraro C, Silvestris F. The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis. Ann N Y Acad Sci 2005; 1051: 421-32. (Pubitemid 41362772)
32. Grande JP. Mechanisms of progression of renal damage in lupus nephritis: pathogenesis of renal scarring. Lupus 1998; 7: 604-10. (Pubitemid 29008226)
33. Ferraccioli G, Romano GG. Renal interstitial cells, proteinuria and progression of lupus nephritis: New frontiers for old factors. Lupus 2008; 17: 533-40. (Pubitemid 351955428)
34. Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu CY, Nagaraja HN. Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol 2005; 16: 467-73. (Pubitemid 41725143)
35. Rovin BH, Song H, Hebert LA, Nadasdy T, Nadasdy G, Birmingham DJ, et al. Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus. Kidney Int 2005; 68: 1825-33. (Pubitemid 43169928)
36. Song H, Chan J, Rovin BH. Induction of chemokine expression by adiponectin in vitro is isoform dependent. Transl Res 2009; 154: 18-26.
37. Zhang X, Jin M, Wu H, Nadasdy T, Nadasdy G, Harris N, et al. Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int 2008; 74: 799-807.
38. Hinze CH, Suzuki M, Klein-Gitelman M, Passo MH, Olson J, Singer NG, et al. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. Arthritis Rheum 2009; 60: 2772-81.